...
首页> 外文期刊>Cell cycle >Reprogramming specific gene expression pathways in B-cell lymphomas.
【24h】

Reprogramming specific gene expression pathways in B-cell lymphomas.

机译:重新编程B细胞淋巴瘤中的特定基因表达途径。

获取原文
获取原文并翻译 | 示例
           

摘要

The BCL6 transcriptional repressor is normally expressed during the germinal center phase of B-cell differentiation. Germinal center B-cells typically undergo rapid proliferation in spite of accumulating DNA damage caused by class switch recombination and somatic hypermutation. BCL6 is required to license B-cells for the germinal center reaction and its down regulation appears to be important for cells to exit this stage and undergo further differentiation. BCL6 appears to mediate these biological effects by recruiting corepressor complexes to silence critical cell cycle checkpoint and differentiation related genes. Based on our data and recent publications, we propose that these gene pathways are regulated through distinct transcriptional mechanisms, which can be specifically targeted to reprogram B-cells preferentially for either growth suppression and apoptosis, or differentiation. As BCL6 plays a central role in the pathogenesis of diffuse large B-cell lymphoma, we predict that targeting BCL6 transcriptional repression complexes in malignant B-cells may constitute a novel form of transcription therapy for lymphomas and possibly other tumors.
机译:BCL6转录阻遏物通常在B细胞分化的生发中心阶段表达。尽管积累了由类别开关重组和体细胞超突变引起的DNA损伤,但生发中心B细胞通常会迅速增殖。需要BCL6许可B细胞进行生发中心反应,其下调似乎对于细胞退出此阶段并进行进一步分化非常重要。 BCL6似乎通过募集corepressor复合物来沉默关键的细胞周期检查点和分化相关基因来介导这些生物学效应。根据我们的数据和最新出版物,我们建议这些基因途径通过不同的转录机制进行调控,这些转录机制可以特异性地靶向重编程B细胞,优先用于生长抑制和凋亡或分化。由于BCL6在弥漫性大B细胞淋巴瘤的发病机理中起着核心作用,因此我们预测在恶性B细胞中靶向BCL6转录抑制复合物可能构成针对淋巴瘤和其他肿瘤的新型转录治疗形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号